Product
4-Demethyl-4-cholesteryloxycarbonylpenclomedine
1 clinical trial
1 abstract
2 indications
Indication
Advanced CancerIndication
NSCLCClinical trial
A Phase I Trial to Evaluate Safety and Tolerance of Intravenous 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Adult Subjects With Cancer Involving the CNSStatus: Completed, Estimated PCD: 2022-10-01